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Abstract
In recent years, electronic (e)‐cigarettes have dramatically increased in popularity as 
an alternative to conventional cigarettes. Little is known about the effects of e‐cigarette 
vapor (EV) on bacteria that colonize the nasopharynx, including methicillin‐resistant 
Staphylococcus aureus (MRSA). As most cases of pneumonia can be traced to bacteria in 
a patient's nasopharynx, increased virulence in potential pathogens could have direct 
consequences clinically for these patients. And because bacterial colonizers are spread 
between humans, increased virulence in one subject has implications for the commu-
nity. There is accumulating evidence that exposure to cigarette smoke (CS) increases the 
pathogenicity of MRSA, as well as its dampening effects on the host immune system. EV 
exposure has also been demonstrated to increase MRSA virulence both in vitro and in 
a murine model of pneumonia. In this chapter, we will compare the virulence changes 
reported in MRSA exposed to CS vs. those exposed to EV, as well as proposed mecha-
nisms and therapeutic targets.
Keywords: electronic cigarettes, e‐cigarette vapor, cigarette smoke, staphylococcal 
virulence, MRSA, pneumonia
1. Introduction
Smoking is a leading cause of preventable morbidity and mortality worldwide, with an 
estimated 6 million premature deaths per year (10% of all deaths globally) attributable to 
cigarette smoke (CS) exposure [1]. Health ramifications of smoking include cardiovascular 
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disease, malignancy, and chronic obstructive pulmonary disease [1]. In addition, smokers 
have increased rates of serious infections of the respiratory tract.
Tobacco smoke has many known carcinogenic and inflammatory effects on the airways and 
lungs [2]. Each puff of a cigarette exposes the epithelial and immune cells of the airway to more 
than 7000 chemicals including toxins such as acrolein, formaldehyde, and benzo(a)pyrene, as 
well as nicotine, the compound responsible for the addictive potential of both conventional 
cigarettes and e‐cigarettes [1]. In chronic smokers, this chemical bath induces an inflammatory 
response in the airway that simultaneously damages the structural integrity of the airways 
and reduces the ability of host cells to clear pathogens from the airway [1–3]. Bacterial colo-
nizers of the airways, including pathogens such as methicillin‐resistant Staphylococcus aureus 
(MRSA), are exposed to the same toxic cigarette smoke milieu.
A newly fashioned nicotine delivery device, known commercially as electronic (e)‐cigarette or 
vape pen was introduced to the international market for the first time in 2007 [4]. E‐cigarettes 
have experienced a dramatic surge in popularity in the last decade. Their use among youth 
is a pressing public health issue, with prevalence of use surpassing that of tobacco cigarettes 
[5]. About 13.4% of USA youth are current users of e‐cigarettes, a higher rate than that of 
traditional tobacco use. This corresponds to 3 million middle and high school students, up 
from 2.46 million in 2014 [6]. Moreover, e‐cigarettes were found to increase smoking initia-
tion by more than 200% with a prediction to achieve a corresponding 6% increase in smoking 
prevalence by 2060 [7]. One out of every four current e‐cigarettes users in Spain have never 
smoked before [7, 8].
E‐cigarettes consist of a cartridge containing nicotine in a propylene glycol (PG) and/or veg-
etable glycerin (VG) solvent that is heated and then vaporized via an atomizer; this vapor is 
subsequently inhaled, resulting in similar nicotine delivery to the bloodstream as conven-
tional cigarettes. E‐cigarettes have been promoted as a safer alternative to tobacco products, 
with fewer adverse effects and as being efficient in smoking cessation. In this respect, a recent 
study conducted in 28 European countries suggested a positive public health impact for e‐cig-
arette for the tobacco smokers accompanied by minimal potential harm due to use by never 
smokers [9]. However, this study based its findings on a little‐harm model of e‐cigarettes, 
which is not supported by scientific data. E‐cigarette components have been shown to contain 
many hazards for the respiratory system. In 2009, the US FDA found detectable levels of toxic 
cancer‐causing chemicals in e‐cigarette cartridges [10]. Many other components such as alde-
hydes, metals, volatile organic compounds, phenolic compounds, polycyclic aromatic hydro-
carbons, and tobacco alkaloids were identified in e‐cigarette cartridges, refill solutions, and 
aerosols [11]. All of these hazardous components in turn will come in contact with respiratory 
colonizing pathogens, including S. aureus, and may promote pro‐virulent changes.
S. aureus are Gram‐positive cocci with the potential to cause serious infections including bac-
teremia, endocarditis, and pneumonia, as well as skin and soft tissue infections ranging from 
impetigo to necrotizing fasciitis. More than one‐third of the general population is asymp-
tomatically colonized with S. aureus on either a transient or persistent basis, most frequently 
in the nose, throat, and perineum [12–14]. These colonizers are frequently the source of host 
staphylococcal infections, and patients with positive nasal swabs for S. aureus are known to 
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be at high risk of nosocomial and surgical site infections [15]. Persistent carriers frequently 
have a higher bacterial load and a corresponding increased risk of subsequent staphylococcal 
infection relative to intermittent carriers [15].
Smokers are more likely than nonsmokers to be colonized with S. aureus, defined as >500 
colony forming units (CFU) detected, with rates of colonization increasing with duration and 
frequency of smoking [14, 16, 17]. Smokers have an increased incidence of invasive staphy-
lococcal infections than nonsmokers and have higher mortality as well [17–19]. Additionally, 
smokers are at greater risk of being colonized with antibiotic resistance S. aureus (MRSA) 
than nonsmokers. This finding is of note because MRSA infections have higher morbidity 
and mortality than methicillin‐sensitive strains [20, 21]. Accumulating evidence suggests that 
this susceptibility to MRSA/staphylococcal infection may reflect not only the impairment of 
host defenses induced by chronic exposure to cigarette smoke, but also provirulent changes 
in commensal MRSA itself as a consequence of the same chronic cigarette smoke exposure.
To our knowledge, there are no epidemiologic studies of staphylococcal infection in e‐cigarette 
users. However, recent work from our laboratory suggests that e‐cigarette vapor (EV) may 
induce a similar stress response as conventional cigarette smoke in exposed Staphylococcus, 
resulting in a propathogenic phenotype.
2. Conventional cigarette smoke promotes increased staphylococcal 
virulence
MRSA often colonizes the nasopharynx, where it is exposed to everything that an individual 
inhales, including cigarette smoke (CS) or e‐cigarette vapor (EV). Bacteria from the nasophar-
ynx have the potential to travel to the lungs, causing pneumonia, or to the skin, where com-
promises in the epithelial barrier such as ulcers, abrasions, or surgical incisions provide ports 
of entry for invasive staphylococcal infection. The initial stage preceding infection is coloniza-
tion of the human host. Transient colonization of the nasopharynx by S. aureus is more com-
mon in healthy individuals than persistent colonization (30 vs. 20%), which usually entails a 
larger bacterial burden and increased risk of infection [15]. Smokers are known to have higher 
rates of persistent colonization of the nasopharynx by MRSA relative to the general popula-
tion [17]. The phenotypic changes in S. aureus induced by in vitro CS exposure favor persistent 
colonization via increasing adhesion to host cells and by inducing biofilm formation, reduc-
ing the ability of host immune effectors to limit colonization [22].
2.1. MRSA hydrophobicity changes induced by cigarette smoke
Our own studies demonstrate that CS extract (CSE) exposure results in a dose‐dependent 
increase in MRSA surface hydrophobicity that is persistent and possibly even heritable [23, 
24]. Increased hydrophobicity is associated with increased bacterial interactions with host 
epithelial cells [25]. Thus, we evaluated the adherence of MRSA to human keratinocytes 
(HaCaT cells) in vitro and found that pretreatment with CSE increased adherence from 28% 
(control) to 52% (CSE‐MRSA). These findings are likely due to increased interaction with 
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 epithelial cell surfaces because of the increased surface hydrophobicity induced by CSE expo-
sure. Increased capacity to adhere to epithelial cells as a consequence of CS exposure may 
explain the increased MRSA carriage rates in smokers.
2.2. Staphylococcal surface charge changes induced by cigarette smoke
CSE exposure induced dramatic changes in surface charge, in a dose‐dependent manner. 
With increasing concentrations of CSE, the surfaces of S. aureus and MRSA became less nega-
tive. The negative surface charge of bacteria is protective against a variety of host defense 
mechanisms, including antimicrobial peptide (AMP) binding. Changes in surface charge 
were persistent for over 24 h post‐CSE exposure. These changes suggest that the CSE expo-
sure may result in persistent, heritable changes. Additionally, daily intermittent exposure 
to CSE over the course of 3 or 4 days—reflecting the pattern of exposure experienced by 
the nasopharyngeal flora of a smoker—resulted in an additive increase in surface charge 
alterations.
Cigarette smoke contains thousands of compounds, making the identification of specific etio-
logic agent inducing change in surface charge difficult. However, we hypothesized that reac-
tive species such as free radicals and carbon monoxide likely played a role. To assess the 
contribution of reactive species, CSE was stored for 24 h at 4°C to allow time for volatile gases 
to evaporate and for some degradation of reactive oxygen species. The “aged” CSE induced 
a less‐anionic surface charge in exposed MRSA; however, it had significantly less potency 
relative to fresh CSE. Thus, while reactive species account for some measure of the observed 
surface changes in MRSA, some of the more stable elements of CS contribute as well. One 
such component, present in both fresh and aged CSE—as well as e‐cigarette vapor—is nico-
tine. We found that nicotine at 3 and 6 mg/mL induced a dose‐dependent shift toward a less 
negative surface charge, suggesting that it likely plays a role in the altered surface charge of 
CSE‐exposed MRSA. Finally, we sedimented CSE and exposed MRSA solely to these particu-
lates and found no effect on surface charge.
The cell surface charge changes are mediated in part by expression of the mprF gene, which 
encodes a membrane protein involved in the shift to a less negative surface charge. Exposure 
to CSE induced a 1.8‐fold increase in expression of mprF RNA, and CSE did not induce signifi-
cant surface charge change in an mprF knock‐out strain of S. aureus (SA113 ∆mprF), relative to 
wild‐type bacteria, further supporting an important role of this pathway in this aspect of the 
staphylococcal response to CS exposure.
2.3. Cigarette smoke exposure increases S. aureus resistance to antimicrobial defenses
Aspiration of nasopharyngeal colonizers is a common occurrence and provides an opportu-
nity for potential pathogens to cause airway infection. Numerous immunologic defenses are 
in place to protect against this outcome, including mechanical clearance of bacteria by the 
mucociliary elevator and destruction of remaining bacteria by immune cells within the air-
ways. Alveolar macrophages, which destroy bacteria by mechanisms including phagocytosis, 
antimicrobial peptide (AMP) production, and respiratory burst, are an important component 
of host defense against pulmonary infection by bacteria.
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CSE exposure may induce MRSA resistance to the bacteriocidal activities of these cells by 
multiple mechanisms. In vitro, CSE‐exposed MRSA was resistant to killing by a murine alveo-
lar macrophage cell line (MH‐S), with a fourfold increase in survival relative to control (p < 
0.0001). This outcome was not due to a cytotoxic effect on the macrophages, as macrophage 
cell death rate was comparable regardless of whether they were infected with CSE‐treated 
MRSA or control bacteria. Phagocytosis of fluorescently tagged MRSA‐GFP was unaffected 
by CSE exposure—suggesting that the difference in survival reflected that the CSE‐exposed 
MRSA were better able to endure intracellular killing mechanisms including exposure to anti-
microbial peptides and other toxic compounds and reactive oxygen species found in the pha-
golysosome. Indeed, CSE exposure increased resistance to killing by the human AMP LL‐37, 
with twofold increases in both MIC and MBC relative to control bacteria. Decreased suscep-
tibility to AMPs, which are produced by neutrophils, macrophages, and epithelial cells, sug-
gests a significant increase in pathogenicity.
Potential mechanisms of this resistance include changes in cell surface charge and decreased 
rate of cell division induced by CS. Rapidly dividing bacteria are more sensitive to many anti-
microbials, including conventional antibiotics and AMPs. Kristian et al. showed that growth 
suppression using bacteriostatic antibiotics allowed S. aureus decreased susceptibility to kill-
ing by AMPs [26]. Growth curves at various concentrations of CSE‐demonstrated inhibition 
of bacterial growth in a CSE dose‐dependent fashion. The growth defect induced by CSE 
resolved with removal of CSE; however, it is possible that a clonal population continues to 
divide slowly and that this population is better equipped to persist in the face of subsequent 
stressors.
Interestingly, the changes induced by CSE exposure also seemed to induce resistance to mem-
brane solublization by detergent. CSE‐MRSA had similar death rates to control bacteria dur-
ing the first few minutes of incubation with detergent (Triton‐X), but demonstrated improved 
survival subsequently, suggesting further protective cell membrane changes induced by CSE.
Findings in vivo in a murine model of pneumonia supported in vitro results, with CSE expo-
sure resulting in increased staphylococcal persistence in the lungs and an increase in over-
whelming infection. Mice infected with CSE‐exposed MRSA had increased bacterial burdens 
in the lungs at 8 and 24 h relative to those infected with control bacteria, demonstrating that 
CSE‐MRSA are better able to persist in the face of pulmonary immune defenses. Additionally, 
40% of mice infected with a higher inoculum of CSE‐exposed MRSA died within 48 h, vs. only 
10% of those infected with unexposed MRSA.
2.4. Potential consequences of virulence changes induced by cigarette smoke
While pulmonary infection with MRSA is devastating, much of the morbidity and mortality 
associated with MRSA infections is due to soft tissue infections. Because bacteria colonizing 
the nasopharynx do not necessarily remain there, propathogenic changes induced by CS in 
the nasopharynx are of concern for staphylococcal infections beyond the pulmonary system. 
Coughing, sneezing, etc. lead to significant opportunity to transfer MRSA from nasal pas-
sages and upper airway to the skin, where an increased capacity to adhere to and invade 
epithelial cells—as well as resistance to AMPs—reflect serious potential consequences of the 
Effects of Electronic (e)-Cigarette Vapor on Staphylococcal Virulence: Are E-Cigarettes Safer than Conventional...
http://dx.doi.org/10.5772/66154
109
pro‐pathogenic effects of cigarette smoke for skin and soft tissue infections. Finally, MRSA 
are transmitted between humans in the community as well. Thus, more virulent strains gen-
erated by CS exposure may put the community at higher risk of invasive staphylococcal 
diseases.
3. E‐cigarette vapor increases staphylococcal virulence and impairs innate 
immune function
As the popularity of e‐cigarettes skyrockets, it becomes increasingly important to establish 
whether e‐cigarettes are indeed a safer alternative to conventional cigarettes. Simply, it is a 
battery operated device designed to deliver nicotine with flavors and other chemicals to users 
in vapor form instead of smoke. E‐cigarette vapor (EV) contains a far more limited array of 
chemicals than cigarette smoke, resulting from vaporization of e‐liquid containing nicotine, 
propylene glycol (PG), and vegetable glycerin (VG) solvents, with different flavors added 
in some cases. While PG is not harmful when ingested through the GI tract and is gener-
ally recognized as safe for use as a food additive [27], high wattage heating of these solvents 
results in the production of formaldehyde, aldehyde, and acrolein, resulting in significantly 
increased exposure of the airways to formaldehyde relative to a pack‐day smoker [28]. The 
absorption of nicotine in blood showed no difference between the latest generation e‐ciga-
rettes and conventional cigarettes. Nicotine itself is toxic at high doses, and as described in 
the preceding section, induces a shift in MRSA toward a less negative surface charge which 
confers resistance to AMPs. Thus, e‐cigarette “vaping” is exposing the colonizing bacteria to 
at least two components (formaldehyde and nicotine) with the potential to induce a signifi-
cant stress response.
3.1. MRSA growth suppression by e‐cigarette vapor
We tested the growth kinetics of MRSA cultures during exposure to different components of 
EV extract (EVE) including nicotine, PG, and VG. We also tested a number of different brands 
of e‐cigarettes. EVE suppressed MRSA growth, with cultures failing to achieve logarithmic 
phase. While nicotine mildly inhibited MRSA growth in a dose‐dependent fashion, the vapor-
ized vehicles likely account for most of the suppressive effects observed. Vaporized PG and/
or VG nearly abrogated MRSA growth, to the same degree as EVE [29]. Interestingly, MRSA 
growth suppression was observed in four of five brands, suggesting that the etiologic agent is 
a common component across brands. Thus, as with cigarette smoke, EV imposes significant 
stress on Staphylococcal cells. Bacterial survivors of the noxious exposure are likely to be 
hardier, and thus more difficult to kill.
3.2. Increased hydrophobicity, adherence, and invasion of keratinocytes by e‐cigarette 
vapor exposed MRSA
As with conventional CS, EV promotes a shift in phenotype that supports persistent MRSA col-
onization of the epithelium, as well as increasing the risk of invasive infection. Hydrophobicity 
was markedly increased following EV exposure (by 31%), with a corresponding doubling of 
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MRSA adherence to the human keratinocyte HaCaT cell line. EVE‐exposed MRSA demon-
strated increased invasion of and intracellular persistence within HaCaT cells. These changes 
do not appear to be induced by nicotine, as increasing the nicotine content by fivefold had no 
effect on adherence and invasion.
3.3. E‐cigarette vapor increases MRSA resistance to human antimicrobial peptide LL‐37
Increased survival of internalized MRSA suggests that e‐cigarette exposure may induce 
resistance to killing by epithelial cells. This effect is at least in part a consequence of moder-
ately increased resistance to killing by antimicrobial peptides (AMPs). One of the established 
mechanisms for bacterial virulence is alterations in surface charge. Most bacteria have pre-
dominantly anionic surfaces, which are targeted by the human innate immune system [30, 
31]. One of the human AMPs, LL‐37, acts through charge interactions between its cationic 
surface and the bacterial lipids which are negatively charged [30–32]. EVE exposure increased 
the MIC of LL‐37 from 7 uM in unexposed MRSA to 10 uM in EVE‐MRSA (P = 0.014). As 
with conventional CS, EVE exposure induces a shift in MRSA toward a less negative surface 
charge. In turn, this reduces the propensity of the cationic LL‐37 to bind the bacterial surface 
as it must for antimicrobial activity. This transition in surface charge was independent of the 
level of nicotine in EVE.
3.4. MRSA biofilm induction by e‐cigarette vapor
EV has other pro‐virulent effects on MRSA that may allow the bacteria to cause more severe 
infections—it promotes a moderate increase in biofilm formation. Antibiotics and our own 
immune cells have difficulty penetrating biofilm to kill embedded bacteria, thus allowing 
colonization (or infection) to perpetuate. The increased predilection for biofilm following EV 
exposure may reflect a response to nicotine in the vapor, as nicotine alone induced dose‐
dependent increases in biofilm formation. Interestingly, the increased biofilm formation 
occurring in response to conventional CS seemed to be due primarily to oxidative stress [29]. 
In our studies, MRSA incubated with only nicotine produced more biofilm than control. In 
the exposure to either EV or CS, a novel pathway in inducing MRSA biofilm was suggested 
[23, 29].
3.5. E‐cigarette vapor increases MRSA virulence in a mouse model of pneumonia
In vivo studies in mice also suggested that EV promotes propathogenic features. The same 
murine pneumonia model used to evaluate CS effects on MRSA was employed to deter-
mine EV effects. Mortality was increased in mice infected with EV‐MRSA (25 vs. 0% in mice 
infected with control MRSA, p < 0.05). In addition, bacterial burdens were 10‐fold higher in 
mice infected with EV‐MRSA relative to mice infected with MRSA controls. Exposure to EV 
enhanced both MRSA virulence and MRSA survival [29].
3.6. E‐cigarette vapor induction of MRSA virulence gene expression
Similarly to the effect of CS exposure on MRSA virulence, MRSA exposed to EV was more 
virulent than controls in the biological model. Thus, the expression of several well‐known 
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virulence factors after EV exposure was evaluated. Panton‐Valentine leukocidin (pvl), α‐
hemolysin (hla), coagulase (coa), α‐phenol soluble modulin (psm‐α), intracellular adhesion 
(icaA), staphylococcal protein A (spa), and quorum sensing (agrA) were quantified relative to 
16s rRNA as a housekeeping gene. After EV exposure, the expression of coa and pvl increased 
by 1.68‐ and 1.56‐fold, respectively [29]. Expression of spa did not change with EV exposure 
while icaA, agrA, hla, and psm decreased.
4. Cigarette smoke versus e‐cigarette vapor
These data provide suggestive evidence that EV induces pro‐virulent changes in MRSA 
comparable in type and magnitude to those promoted by exposure to conventional CS. 
Both EV and CS exposures resulted in shifts toward more hydrophobic and less anionic 
surface charges, with increased adherence and invasion of epithelial cells, and resistance 
to killing by the AMP LL‐37. Additionally, the phenotypic changes induced by exposure 
to both inhalants result in significantly increased virulence in a mouse pneumonia model. 
Without running assays in parallel, however, definitive comparisons cannot be made 
(Table 1).
Both CS and EV exposure result in a similar profile based on these assays, likely reflecting 
a general stress response. However, the primary component of the inhalants inducing these 
Cigarette smoke E‐cigarette vapor
Growth ↓↓ *** ↓↓ ****
Hydrophobicity ↑↑ **** ↑ *
Adherence ↑ * ↑↑ **
Invasion ↑↑ ** ↑↑ *
Surface charge changes ++++ **** + ****
Resistance to killing by:
Macrophage ↑↑↑↑ ****
Antimicrobial peptide (AMP) ↑↑ * ↑ *
Cell lysis ↓ ***
Biofilm formation ↑↑ **





Table 1. Comparison of the effects of cigarette smoke and e‐cigarette vapor on MRSA pathogenicity factors and virulence.
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phenotypic changes may be different. This likely reflects that CS contains a multitude of toxic 
chemicals, with a more limited range found in EV. However, both nicotine and degradation 
products of the e‐cigarette liquid solvents are clearly sufficient to induce concerning changes 
in MRSA in vitro. The effects of both CS and EV on MRSA in a physiologic setting may be 
synergistically negative due to the interplay of increased virulence with immunosuppres-
sive effects of these substances on airway cells. Current studies are limited to animal mod-
els, and more research must be carried out to evaluate whether these changes reflect those 
observed following physiologic exposure in human users of both conventional and e‐ciga-
rettes. Additional avenues of research include evaluating the effects of exposure to these sub-
stances on staphylococcal soft tissue infections and bacteremia. In addition, epidemiologic 
studies on the incidence of staphylococcal infections in e‐cigarette users are needed to assess 
the likelihood of our findings having a physiologic correlate.
Comparison of the effects of cigarette smoke and e‐cigarette vapor on MRSA pathogenicity 
factors and virulence.
5. Possible downstream consequences of CS and EV on antibiotic 
resistance in MRSA
The effects of EV and CS on MRSA hydrophobicity, surface charge, virulence, and resistance 
to killing by the innate immune system host defense antimicrobial peptides have potentially 
harmful implications on antistaphylococcal therapy. Vancomycin and daptomycin are the 
only drugs approved by the US FDA for the treatment of MRSA bacteremia and endocardi-
tis [33]. When MRSA causes endocarditis, it is due to the patient's colonizing strain. MRSA 
strains that are induced to relative resistance to cationic host defense peptides, such as platelet 
microbicidal proteins (PMPs), are associated with a proclivity to lead to persistent bacteremia, 
endocarditis, and metastatic infectious foci [34]. In other words, durable changes in MRSA 
physiology by EV and CS may have implications on the ability of this pathogen to establish 
endovascular infection in cases of an otherwise transient bacteremia that is thought to occur 
periodically in healthy hosts but otherwise rapidly quenched by the innate immune system. 
Furthermore, cross‐resistance between host PMPs and cathelicidin and vancomycin and dap-
tomycin have been well‐documented [34–36]. Thus, EV and CS may have serious implications 
on the proclivity of MRSA to develop heteroresistance to these drugs, even before the agents 
are administered to the patient.
Compounding this, resistance concern is the fact that persistent lingering of MRSA in vivo, 
as a result of resistance to host defense peptide killing, further creates a selective pres-
sure environment conducive to further cationic peptide resistance, and hence resistance 
to antimicrobial therapy [37]. These extrapolative hypotheses of the effects of EV and CS 
have yet to be proven, but if they are, have far greater public health implications than 
once thought.
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